Is America Getting “Ripped Off” on Drug Prices?

Just recently, the House Ways and Means Committee passed Speaker Nancy Pelosi’s drug pricing bill which would lower prices on 250 drugs. To accomplish her goal, she plans to implement a “International Pricing Index” (IPI). While it might sound like a workable solution (in theory), it could lead to several disastrous consequences, especially for the […]

STOP Act will Help Prevent Bad Products Entering the U.S.

The opioid epidemic has grown to become a critical problem in communities across the country. While many levels of government and a variety of task forces are working to find ways to tackle it, one easy way to help would be to close off unchecked shipments from foreign countries, like China, through the U.S. Postal […]

Forbes: Biosimilar Competition Will Lower Consumer Prices

When it comes to drug prices, what’s dominating the headlines is bad news story after bad news story. Turing Pharmaceuticals raised the price of an old AIDS drug by more than 5,000 percent overnight, and Valeant Pharmaceuticals International raised a blood pressure drug price by nearly 3,000 percent since 2013, among other consumer losing examples. […]

ACI Experts Write on the Health and Economic Effects of Counterfeit Drugs

Today’s American Health & Drug Benefits (AH&DB) Journal, a peer-reviewed forum, published an article written by three ACI experts — Erwin A. Blackstone, Professor of Economics at Temple University; Joseph P. Fuhr, Jr., Professor of Economics at Widener University; and Steve Pociask, President of the American Consumer Institute, Center for Citizen Research.  The article can […]